4//SEC Filing
Lanman Richard B. 4
Accession 0001628280-19-010686
CIK 0001576280other
Filed
Aug 12, 8:00 PM ET
Accepted
Aug 13, 4:33 PM ET
Size
19.6 KB
Accession
0001628280-19-010686
Insider Transaction Report
Form 4
Lanman Richard B.
Chief Medical Officer
Transactions
- Exercise/Conversion
COMMON STOCK
2019-08-09$4.18/sh+2,307$9,643→ 141,632 total - Exercise/Conversion
COMMON STOCK
2019-08-09$8.80/sh+3,458$30,430→ 145,090 total - Sale
COMMON STOCK
2019-08-09$104.80/sh−16,060$1,683,088→ 117,631 total - Sale
COMMON STOCK
2019-08-09$105.69/sh−25,520$2,697,209→ 92,111 total - Sale
COMMON STOCK
2019-08-09$107.18/sh−500$53,590→ 82,015 total - Exercise/Conversion
STOCK OPTION (RIGHT TO BUY)
2019-08-09−2,307→ 15,371 totalExercise: $4.18Exp: 2027-05-30→ COMMON STOCK (2,307 underlying) - Exercise/Conversion
STOCK OPTION (RIGHT TO BUY)
2019-08-09−3,458→ 42,655 totalExercise: $8.80Exp: 2028-08-21→ COMMON STOCK (3,458 underlying) - Sale
COMMON STOCK
2019-08-09$106.47/sh−9,596$1,021,686→ 82,515 total - Sale
COMMON STOCK
2019-08-09$103.79/sh−11,399$1,183,102→ 133,691 total
Footnotes (9)
- [F1]These shares were sold under a pre-arranged sales plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. Some of the shares sold were acquired contemporaneously upon the cashless exercise of one or more stock options at an exercise price of $4.18 or $8.80 per share.
- [F2]The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $103.10 to $104.08. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected.
- [F3]The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $104.11 to $105.10. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected.
- [F4]The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $105.11 to $106.10. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected.
- [F5]The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $106.11 to $107.02. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected.
- [F6]The stock option vests and becomes exercisable in equal monthly installments over 48 months commencing on April 1, 2017.
- [F7]The expiration date of May 31, 2027 reported in the Reporting Person's prior Form 4 filings was in error.
- [F8]The stock option vests and becomes exercisable in equal monthly installments over 48 months commencing on August 22, 2018.
- [F9]The expiration date of August 22, 2028 reported in the Reporting Person's prior Form 4 filings was in error.
Documents
Issuer
Guardant Health, Inc.
CIK 0001576280
Entity typeother
Related Parties
1- filerCIK 0001721003
Filing Metadata
- Form type
- 4
- Filed
- Aug 12, 8:00 PM ET
- Accepted
- Aug 13, 4:33 PM ET
- Size
- 19.6 KB